Related Experiment Videos
Hemagglutination assay for human serum fibronectin
Journal of Immunological Methods
|May 10, 1985
Summary
A new hemagglutination assay quantifies human serum fibronectin (Fn) by leveraging its gelatin-binding ability. This simple, rapid method is sensitive enough for clinical use in normal and pathologic sera.
Area of Science:
- Biochemistry
- Immunology
- Clinical Chemistry
Background:
- Fibronectin (Fn) is a crucial extracellular matrix protein involved in cell adhesion and various physiological processes.
- Accurate quantification of serum fibronectin is important for diagnosing and monitoring various pathological conditions.
- Existing methods for fibronectin measurement may be complex or require specialized equipment.
Purpose of the Study:
- To describe a novel hemagglutination assay for the quantitative measurement of human serum fibronectin (Fn).
- To establish the sensitivity and reproducibility of the developed assay.
- To assess the suitability of the assay for clinical applications.
Main Methods:
- The assay utilizes the known capacity of fibronectin to bind to gelatin.
- Purified and serum fibronectin were tested for their ability to agglutinate sheep red blood cells.
- Sheep red blood cells were treated with chromic chloride and coated with gelatin.
Main Results:
- The developed hemagglutination assay demonstrated quantitative and reproducible results.
- The assay detected fibronectin concentrations as low as 7 micrograms/ml.
- The assay is simple, rapid, and does not require specialized laboratory equipment.
Conclusions:
- A sensitive and reproducible hemagglutination assay for human serum fibronectin has been developed.
- The assay's simplicity and sensitivity make it suitable for measuring fibronectin levels in both normal and pathological sera.
- This method offers a practical tool for clinical laboratories and research settings.